For the Inventor, By the Inventor

Enter assignee name

Research Triangle Park, NC, United States of America

Alphavax, Incorporated

USPTO Granted Patents = 19

% Expired Patents = 10.5

CIPO Patents = 6

EPO Patents = 14

Trademarks = 1

Forward Citations = 326

Loading Chart...

Loading Chart...

25 inventors (with patents filed for the assignee):

Jonathan F Smith (16 out of 41 patents)

Kurt Iver Kamrud (9 out of 24 patents)

Bolyn Hubby (7 out of 7 patents)

4. Jon O Rayner (6 out of 6 patents)

5. Sergey A Dryga (5 out of 36 patents)

6. Elizabeth A Reap (5 out of 5 patents)

7. Laura Copp (3 out of 3 patents)

8. Ian Caley (3 out of 4 patents)

9. Maureen Maughan (3 out of 4 patents)

10. Vernon McNeil Coffield, Iii (2 out of 3 patents)

11. Jonathan O Rayner (2 out of 2 patents)

12. Ronald I Swanstrom (1 out of 5 patents)

13. Lynn Morris (1 out of 2 patents)

14. Todd L Talarico (1 out of 1 patent)

15. Roberto A DePaz (1 out of 1 patent)

19 patents: Sort by Forward Citations

1. 10570416 - TC-83-derived alphavirus vectors, particles and methods (2020-02-25),

2. 10111943 - Alphavirus replicon particles matched to protein antigens as immunological adjuvants (2018-10-30),

3. 9597414 - Use of microRNAs to control virus helper nucleic acids (2017-03-21),

4. 9441247 - TC-83-derived alphavirus vectors, particles and methods (2016-09-13),

5. 9416370 - Alphavirus replicon particles matched to protein antigens as immunological adjuvants (2016-08-16),

6. 9187729 - Alphavirus and alphavirus replicon particle formulations and methods (2015-11-17),

7. 9079943 - TC-83-derived alphavirus vectors, particles and methods (2015-07-14),

8. 8709441 - TC-83-derived alphavirus vectors, particles and methods (2014-04-29),

9. 8680258 - Use of microRNAs to control virus helper nucleic acids (2014-03-25),

10. 8617533 - Multi-antigenic alphavirus replicon particles and methods (2013-12-31),

11. 8460913 - Promoterless cassettes for expression of alpha virus structural proteins (2013-06-11),

12. 8263092 - Alphavirus replicon particles as immunological adjuvants (2012-09-11),

13. 7910716 - Nucleic acids encoding modified South African HIV-1 subtype C gag proteins (2011-03-22),

14. 7850977 - Promoterless cassettes for expression of alphavirus structural proteins (2010-12-14),

15. 7442381 - Alphavirus replicons and helper constructs (2008-10-28),

Alphavax, Incorporated is a biotechnology company specializing in the development and production of innovative and safe vaccines. Our mission is to address global healthcare challenges by providing effective vaccines that protect and improve the lives of people worldwide. With a strong commitment to research and development, we leverage cutting-edge technology and scientific expertise to create next-generation vaccines targeting infectious diseases. Visit our website to learn more about our groundbreaking vaccine solutions.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

19 Patents

#22 in Research Triangle Park, NC

#381 in North Carolina

#17,113 in US

#32,592 in the World

Research Triangle Park, NC, United States of America

Alphavax, Incorporated

Forward Citations = 326

25 inventors:

Jonathan F Smith (16 out of 41 patents)

Kurt Iver Kamrud (9 out of 24 patents)

Bolyn Hubby (7 out of 7 patents)

4. Jon O Rayner (6 out of 6 patents)

5. Sergey A Dryga (5 out of 36 patents)

Please report any incorrect information to [email protected]

Loading…